πŸ‡ΊπŸ‡Έ FDA
Patent

US 8563575

Fused heterocyclic compounds

granted A61KA61K31/4353A61K31/4355

Quick answer

US patent 8563575 (Fused heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4353, A61K31/4355, A61K31/437, A61K31/4427